Current Hypertension Reports

, Volume 15, Issue 5, pp 433–443

Evaluation of Hypertension in Children

Pediatric Hypertension (JT Flynn, Section Editor)

Abstract

Hypertension is an important public health problem, and increasingly children are being diagnosed with primary hypertension. As the list of secondary causes of hypertension is extensive, pediatric practitioners increasingly need to decide on investigations needed for evaluating children presenting with high blood pressure. The differentiation between primary and secondary hypertension is paramount to understanding this important health issue, since many forms of secondary hypertension require specific treatment. The review evaluates the current available guidelines and practice patterns for evaluating children with elevated blood pressure. The review also aims to provide a framework for cost-effective evaluation strategies for children with elevated blood pressure based on current recommendations and evidence.

Keywords

Hypertension Primary hypertension Secondary hypertension Evaluation Children Stage 1 hypertension Stage 2 hypertension Reno-vascular hypertension Workup Renal ultrasonography Renin PRA Monogenic hypertension Microalbuminuria Baseline evaluation Echocardiography High blood pressure BP Low renin hypertension ABPM BP measurement Pediatric hypertension 

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Din-Dzietham R, Liu Y, Bielo MV, Shamsa F. High blood pressure trends in children and adolescents in national surveys, 1963 to 2002. Circulation. 2007;116(13):1488–96.PubMedCrossRefGoogle Scholar
  2. 2.
    • Flynn J. The changing face of pediatric hypertension in the era of the childhood obesity epidemic. Pediatr Nephrol. 2012. Review discussing the changing etiology of pediatric hypertension. The review highlights the importance of identifying the growing pediatric populations of patients with primary hypertension. Google Scholar
  3. 3.
    • Kapur G, Ahmed M, Pan C, Mitsnefes M, Chiang M, Mattoo TK. Secondary hypertension in overweight and stage 1 hypertensive children: a Midwest Pediatric Nephrology Consortium report. J Clin Hypertens (Greenwich). 2010;12(1):34–9. Multicenter study reporting on the existing variability in evaluation of children with hypertension. The study also highlights the potential limitations of evaluation decisions based on hypertension stages as recommended in the fourth Task Force report.CrossRefGoogle Scholar
  4. 4.
    Kapur G, Mattoo TK. Primary hypertension. In: Flynn JT, Ingelfinger JR, Portman RJ, editors. Pediatric hypertension. New York: Humana Press; 2011. p. 342–56.Google Scholar
  5. 5.
    •• National High Blood Pressure Education Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2 Suppl 4th Report):555–76. The recommendations by an expert panel are universally accepted guidelines on pediatric hypertension. They also propose stratifying evaluation based on hypertension staging in order to develop a more cost-effective approach to evaluation of hypertension in children.Google Scholar
  6. 6.
    Butani LMB. Casual blood pressure methodology. In: Flynn JT, Ingelfinger JR, Portman RJ, editors. Pediatric hypertension. New York: Humana Press; 2011. p. 113–34.CrossRefGoogle Scholar
  7. 7.
    Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005;45(1):142–61.PubMedCrossRefGoogle Scholar
  8. 8.
    • Flynn JT. Ambulatory blood pressure monitoring in children: imperfect yet essential. Pediatr Nephrol. 2011;26(12):2089–94. Review on ABPM in children.PubMedCrossRefGoogle Scholar
  9. 9.
    • Flynn JT, Urbina EM. Pediatric ambulatory blood pressure monitoring: indications and interpretations. J Clin Hypertens (Greenwich). 2012;14(6):372–82. Review on ABPM in children.CrossRefGoogle Scholar
  10. 10.
    •• Lurbe E, Cifkova R, Cruickshank JK, Dillon MJ, Ferreira I, Invitti C, et al. Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens. 2009;27(9):1719–42. Recommendations by an expert panel on pediatric hypertension. The sections on the evaluation of target organ damage and low renin hypertension in children with elevated blood pressure are comprhensive and helpful in clinical decision making.PubMedCrossRefGoogle Scholar
  11. 11.
    •• Urbina E, Alpert B, Flynn J, Hayman L, Harshfield GA, Jacobson M, et al. Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the council on cardiovascular disease in the young and the council for high blood pressure research. Hypertension. 2008;52(3):433–51. Accepted norms for ABPM interpretation in children.PubMedCrossRefGoogle Scholar
  12. 12.
    Flynn JT. Differentiation between primary and secondary hypertension in children using ambulatory blood pressure monitoring. Pediatrics. 2002;110(1 Pt 1):89–93.PubMedCrossRefGoogle Scholar
  13. 13.
    Hodgkinson J, Mant J, Martin U, Guo B, Hobbs FD, Deeks JJ, et al. Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review. BMJ. 2011;342:d3621.PubMedCrossRefGoogle Scholar
  14. 14.
    Lee SH, Kim JH, Kang MJ, Lee YA, Won Yang S, Shin CH. Implications of nocturnal hypertension in children and adolescents with type 1 diabetes. Diabetes Care. 2011;34(10):2180–5.PubMedCrossRefGoogle Scholar
  15. 15.
    Seeman T, Palyzova D, Dusek J, Janda J. Reduced nocturnal blood pressure dip and sustained nighttime hypertension are specific markers of secondary hypertension. J Pediatr. 2005;147(3):366–71. Epub 2005/09/27.PubMedCrossRefGoogle Scholar
  16. 16.
    Swartz SJ, Srivaths PR, Croix B, Feig DI. Cost-effectiveness of ambulatory blood pressure monitoring in the initial evaluation of hypertension in children. Pediatrics. 2008;122(6):1177–81. Epub 2008/12/03.PubMedCrossRefGoogle Scholar
  17. 17.
    Flynn E, Flavin A. General practitioner's reported use of clinical guidelines for hypertension and ambulatory blood pressure. Irish Med J. 2012;105(3):89–91. Epub 2012/05/09.Google Scholar
  18. 18.
    • Kapur G. What do I need to know to start ambulatory blood pressure monitoring for children with hypertension? Available at http://www2.aap.org/sections/nephrology/NephrologyNewsletterSummer2012.pdf Accessed 05/2013. Review focusing on information needed to start ABPM in a pediatric setting. The review also elaborates on the factors leading to limited use of ABPM which is universally recommended by experts as being indispensible for hypertension evaluation in children.
  19. 19.
    Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA: J Am Med Assoc. 2003;289(19):2560–72. Epub 2003/05/16.CrossRefGoogle Scholar
  20. 20.
    Kaplan N. Initial evaluation of the hypertensive adult. Available at http://www.uptodate.com/contents/initial-evaluation-of-the-hypertensive-adult Accessed 05/2013.
  21. 21.
    •• Baracco R, Kapur G, Mattoo T, Jain A, Valentini R, Ahmed M, et al. Prediction of primary vs secondary hypertension in children. J Clin Hypertens (Greenwich). 2012;14(5):316–21. A retrospective study reporting the limitations of routine testing for thyroid funtion tests, plasma renin activity, serum aldosterone and urinary catecholamines in children. The study also reports on increased risk for secondary hypertension in children <12 years old and hypertensive children with an abnormal renal ultrasound.CrossRefGoogle Scholar
  22. 22.
    • Brewer ED. Evaluation of hypertension in childhood diseases. In: Avner ED, Harmon W, Niaudet P, Yoshikawa N, editors. Pediatric nephrology. Berlin: Springer-Verlag; 2009. p. 1519–40. A comprehensive review on evaluation of hypertension in children. The review also proposes a practical approach to hypertension evaluation in children.Google Scholar
  23. 23.
    Flynn J, Zhang Y, Solar-Yohay S, Shi V. Clinical and demographic characteristics of children with hypertension. Hypertension. 2012;60(4):1047–54. Epub 2012/08/16.PubMedCrossRefGoogle Scholar
  24. 24.
    Boneparth A, Flynn JT. Evaluation and treatment of hypertension in general pediatric practice. Clin Pediatr. 2009;48(1):44–9. Epub 2008/10/04.CrossRefGoogle Scholar
  25. 25.
    Mutyala K, Baracco R, Kapur G, Mattoo T. Initial evaluation of hypertension in children by primary care physicians. Presented at Pediatric Academic Societies Meeting Boston, USA; April 28-May 1, 2012.Google Scholar
  26. 26.
    Tullus K. Secondary forms of hypertension. In: Flynn JT, Ingelfinger JR, Portman RJ, editors. Pediatric hypertension. New York: Humana Press; 2011. p. 357–74.CrossRefGoogle Scholar
  27. 27.
    Swinford RD, Portman RJ. Evaluation of the hypertensive pediatric patients. In: Flynn JT, Ingelfinger JR, Portman RJ, editors. Pediatric hypertension. New York: Humana Press; 2011. p. 499–516.CrossRefGoogle Scholar
  28. 28.
    Chen X, Wang Y. Tracking of blood pressure from childhood to adulthood: a systematic review and meta-regression analysis. Circulation. 2008;117(25):3171–80.PubMedCrossRefGoogle Scholar
  29. 29.
    Shear CL, Burke GL, Freedman DS, Berenson GS. Value of childhood blood pressure measurements and family history in predicting future blood pressure status: results from 8 years of follow-up in the Bogalusa Heart Study. Pediatrics. 1986;77(6):862–9.PubMedGoogle Scholar
  30. 30.
    Daniels SR, Kimball TR, Morrison JA, Khoury P, Meyer RA. Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiovascular disease. Am J Cardiol. 1995;76(10):699–701.PubMedCrossRefGoogle Scholar
  31. 31.
    de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol. 1995;25(5):1056–62.PubMedCrossRefGoogle Scholar
  32. 32.
    Sorof JM, Cardwell G, Franco K, Portman RJ. Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension. 2002;39(4):903–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Daniels SR, Loggie JM, Khoury P, Kimball TR. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation. 1998;97(19):1907–11.PubMedCrossRefGoogle Scholar
  34. 34.
    Sheps SG, Frohlich ED. Limited echocardiography for hypertensive left ventricular hypertrophy. Hypertension. 1997;29(2):560–3.PubMedCrossRefGoogle Scholar
  35. 35.
    • Singh A, Satchell SC. Microalbuminuria: causes and implications. Pediatr Nephrol. 2011;26(11):1957–65. An update on microalbuminuria in children.PubMedCrossRefGoogle Scholar
  36. 36.
    Rademacher ER, Sinaiko AR. Albuminuria in children. Curr Opin Nephrol Hypertens. 2009;18(3):246–51. Epub 2009/03/12.PubMedCrossRefGoogle Scholar
  37. 37.
    Assadi F. Relation of left ventricular hypertrophy to microalbuminuria and C-reactive protein in children and adolescents with essential hypertension. Pediatr Cardiol. 2008;29(3):580–4. Epub 2007/11/30.PubMedCrossRefGoogle Scholar
  38. 38.
    Burgert TS, Dziura J, Yeckel C, Taksali SE, Weiss R, Tamborlane W, et al. Microalbuminuria in pediatric obesity: prevalence and relation to other cardiovascular risk factors. Int J Obes (Lond). 2006;30(2):273–80.CrossRefGoogle Scholar
  39. 39.
    Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350(23):2362–74.PubMedCrossRefGoogle Scholar
  40. 40.
    Haffner SM, Gonzales C, Valdez RA, Mykkanen L, Hazuda HP, Mitchell BD, et al. Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study. Diabetologia. 1993;36(10):1002–6.PubMedCrossRefGoogle Scholar
  41. 41.
    Daniels SR, Lipman MJ, Burke MJ, Loggie JM. The prevalence of retinal vascular abnormalities in children and adolescents with essential hypertension. Am J Ophthalmol. 1991;111(2):205–8.PubMedGoogle Scholar
  42. 42.
    Mitchell P, Cheung N, de Haseth K, Taylor B, Rochtchina E, Islam FM, et al. Blood pressure and retinal arteriolar narrowing in children. Hypertension. 2007;49(5):1156–62.PubMedCrossRefGoogle Scholar
  43. 43.
    Skalina ME, Annable WL, Kliegman RM, Fanaroff AA. Hypertensive retinopathy in the newborn infant. J Pediatr. 1983;103(5):781–6.PubMedCrossRefGoogle Scholar
  44. 44.
    Enright PL, Goodwin JL, Sherrill DL, Quan JR, Quan SF. Blood pressure elevation associated with sleep-related breathing disorder in a community sample of white and Hispanic children: the Tucson Children's Assessment of Sleep Apnea study. Archives Pediatr Adolesc Med. 2003;157(9):901–4.CrossRefGoogle Scholar
  45. 45.
    Marcus CL, Greene MG, Carroll JL. Blood pressure in children with obstructive sleep apnea. Am J Respir Crit Care Med. 1998;157(4 Pt 1):1098–103.PubMedCrossRefGoogle Scholar
  46. 46.
    Quan SF, Gersh BJ. Cardiovascular consequences of sleep-disordered breathing: past, present and future: report of a workshop from the National Center on Sleep Disorders Research and the National Heart, Lung, and Blood Institute. Circulation. 2004;109(8):951–7.PubMedCrossRefGoogle Scholar
  47. 47.
    Mindell J, Owens JA. A Clinical Guide to Pediatric Sleep: Diagnosis and Management of Sleep Problems. Philadelphia, PA: Lippincott, Williams & Wilkins; 2003. p. 10.Google Scholar
  48. 48.
    Kirk V, Midgley J, Giuffre M, Ronksley P, Nettel-Aguirre A, Al-Shamrani A. Hypertension and obstructive sleep apnea in Caucasian children. World J Cardiol. 2010;2(8):251–6.PubMedCrossRefGoogle Scholar
  49. 49.
    Dillon MJ, Ryness JM. Plasma renin activity and aldosterone concentration in children. Br Med J. 1975;4(5992):316–9.PubMedCrossRefGoogle Scholar
  50. 50.
    • Tullus K, Brennan E, Hamilton G, Lord R, McLaren CA, Marks SD, et al. Renovascular hypertension in children. Lancet. 2008;371(9622):1453–63. Recommendations for diagnosis of renovascular hypertension in children, detailing clinical presentation, imaging modalities and treatment.PubMedCrossRefGoogle Scholar
  51. 51.
    Mulatero P, Verhovez A, Morello F, Veglio F. Diagnosis and treatment of low-renin hypertension. Clin Endocrinol. 2007;67(3):324–34.CrossRefGoogle Scholar
  52. 52.
    Egan BM, Basile JN, Rehman SU, Davis PB, Grob 3rd CH, Riehle JF, et al. Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial. Am J Hypertens. 2009;22(7):792–801.PubMedCrossRefGoogle Scholar
  53. 53.
    Laragh J. Laragh's lessons in pathophysiology and clinical pearls for treating hypertension. Am J Hypertens. 2001;14(2):186–94.PubMedCrossRefGoogle Scholar
  54. 54.
    •• Marks SD, Tullus K. Update on imaging for suspected renovascular hypertension in children and adolescents. Curr Hypertens Rep. 2012;14(6):591–5. Review evaluating current imaging modalities available for children suspected of having renovascular hypertension.PubMedCrossRefGoogle Scholar
  55. 55.
    Eklof H, Ahlstrom H, Magnusson A, Andersson LG, Andren B, Hagg A, et al. A prospective comparison of duplex ultrasonography, captopril renography, MRA, and CTA in assessing renal artery stenosis. Acta Radiol. 2006;47(8):764–74.PubMedCrossRefGoogle Scholar
  56. 56.
    Li JC, Wang L, Jiang YX, Dai Q, Cai S, Lv K, et al. Evaluation of renal artery stenosis with velocity parameters of Doppler sonography. J Ultrasound Med: Off J Am Inst Ultrasound Med. 2006;25(6):735–42.Google Scholar
  57. 57.
    Ahmed M, Eggleston D, Kapur G, Jain A, Valentini RP, Mattoo TK. Dimercaptosuccinic acid (DMSA) renal scan in the evaluation of hypertension in children. Pediatr Nephrol. 2008;23(3):435–8.PubMedCrossRefGoogle Scholar
  58. 58.
    Simoes e Silva AC, Silva JM, Diniz JS, Pinheiro SV, Lima EM, Vasconcelos MA, et al. Risk of hypertension in primary vesicoureteral reflux. Pediatr Nephrol. 2007;22(3):459–62.PubMedCrossRefGoogle Scholar
  59. 59.
    Stokland E, Hellstrom M, Jakobsson B, Sixt R. Imaging of renal scarring. Acta Paediatr Suppl. 1999;88(431):13–21.PubMedCrossRefGoogle Scholar
  60. 60.
    Barontini M, Levin G, Sanso G. Characteristics of pheochromocytoma in a 4- to 20-year-old population. Ann N Y Acad Sci. 2006;1073:30–7.PubMedCrossRefGoogle Scholar
  61. 61.
    Prisant LM, Gujral JS, Mulloy AL. Hyperthyroidism: a secondary cause of isolated systolic hypertension. J Clin Hypertens (Greenwich). 2006;8(8):596–9.CrossRefGoogle Scholar
  62. 62.
    • Ingelfinger J. Monogenic and polygenic genetic contributions to hypertension. In: Flynn JT, Ingelfinger JR, Portman RJ, editors. Pediatric hypertension. New York: Humana Press; 2011. An updated review on monogenic hypertension and diagnostic strategies for theses disorders.Google Scholar
  63. 63.
    Kuo CF, See LC, Yu KH, Chou IJ, Chiou MJ, Luo SF. Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality. Rheumatology (Oxford). 2013;52(1):127–34.CrossRefGoogle Scholar
  64. 64.
    Niskanen LK, Laaksonen DE, Nyyssonen K, Alfthan G, Lakka HM, Lakka TA, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med. 2004;164(14):1546–51.PubMedCrossRefGoogle Scholar
  65. 65.
    Feig DI, Johnson RJ. The role of uric acid in pediatric hypertension. J Renal Nutr: Off J Counc Renal Nutr Natl Kidney Found. 2007;17(1):79–83.CrossRefGoogle Scholar
  66. 66.
    Johnson RJ, Sanchez-Lozada LG, Mazzali M, Feig DI, Kanbay M, Sautin YY. What are the key arguments against uric Acid as a true risk factor for hypertension? Hypertension. 2013;61(5):948–51.PubMedCrossRefGoogle Scholar
  67. 67.
    Reyes AJ, Leary WP. The increase in serum uric acid induced by diuretics could be beneficial to cardiovascular prognosis in hypertension: a hypothesis. J Hypertens. 2003;21(9):1775–7.PubMedCrossRefGoogle Scholar
  68. 68.
    Waring WS, Convery A, Mishra V, Shenkin A, Webb DJ, Maxwell SR. Uric acid reduces exercise-induced oxidative stress in healthy adults. Clin Sci (Lond). 2003;105(4):425–30.CrossRefGoogle Scholar
  69. 69.
    Agabiti-Rosei E, Mancia G, O'Rourke MF, Roman MJ, Safar ME, Smulyan H, et al. Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension. 2007;50(1):154–60.PubMedCrossRefGoogle Scholar
  70. 70.
    Flynn JT. Evaluation and management of hypertension in childhood. Prog Pediatr Cardiol. 2001;12(2):177–88.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Children’s Hospital of MichiganWayne State University School of MedicineDetroitUSA

Personalised recommendations